❌

Reading view

↗️

Genetic predictors of GLP1 receptor agonist weight loss and side effects

βœ‡Nature - Issue - nature.com science feeds
By: Qiaojuan Jane Su Β· James R. Ashenhurst Β· Wanwan Xu Β· Vinh Tran Β· R. Ryanne Wu Β· Catherine H. Weldon Β· Jingchunzi Shi Β· Barry Hicks Β· Robert K. Bell Β· Katelyn Kukar Bond Β· Zayn Cochinwala Β· Sayantan Das Β· Kahsaia de Brito Β· Devika Dhamija Β· Payambr Dibaeinia Β· Emily DelloRusso Β· Chris Eijsbouts Β· Sarah L. Elson Β· Shirin Fuller Β· Chris German Β· Julie M. Granka Β· Larry Hengl Β· David A. Hinds Β· Reza Jabal Β· Aly Khan Β· Matthew J. Kmiecik Β· Alan Kwong Β· Yanyu Liang Β· Keng-Han Lin Β· Matthew H. McIntyre Β· Alex Moran Β· Carrie Northover Β· Shubham Saini Β· Anjali J. Shastri Β· Suyash Shringarpure Β· Teague Sterling Β· Joyce Y. Tung Β· Noura S. Abul-Husn Β· Stella Aslibekyan Β· Michael V. Holmes Β· Bertram L. Koelsch Β· Adam Auton

Nature, Published online: 08 April 2026; doi:10.1038/s41586-026-10330-z

Identification of genetic variants associated with the efficacy and side effects of GLP1 medications could underpin development of precision medicine approaches in the treatment of obesity.
  •  
  • ↗️
There are no more articles
❌